MUC1 is associated with TFF2 methylation in gastric cancer

Abstract

Background: Emerging evidence has shown that MUC1 and TFF2 play crucial roles in the H. pylori-infected pathogenesis of gastric cancer (GC). A recent study revealed that H. pylori infection induced obviously increased Tff2 methylation levels in Muc1 −/− mice compared with controls. However, little is known of the molecular mechanism on MUC1 regulating the expression of TFF2. Methods: We conducted a correlation analysis of MUC1 and TFF2 in public databases and our adjacent GC tissues. Besides, MUC1 overexpression vector or small interfering RNA (siRNA) was transfected into GC cells to assess the change in TFF2 expression. Furthermore, the methylation status of TFF2 was measured by bisulfite sequencing PCR (BSP).Results: The expression of MUC1 was significantly lower in non-cardia and cardia tumor tissues than that in normal tissues. Downregulation of TFF2 expression was also observed in GC tissues. In addition, we found that MUC1 expression was positively associated with TFF2 expression in GC tissues, especially among GC patients with H. pylori infection. Overexpression of MUC1 in BGC-823 and SGC-7901 cell lines substantially increased the TFF2 expression, whereas knockdown of MUC1 reverted this effect. Moreover, MUC1 was negatively related to the methylation of TFF2 in the co-expression analysis. The results of BSP experiments showed that compared with negative vector group, the methylation level of TFF2 was decreased in GC cells transfected with MUC1 overexpression vector. Additionally, survival analysis indicated that GC patients with lower level of MUC1 or TFF2 had a worse outcome. Conclusion: Our results indicated that MUC1 was associated with the methylation of TFF2, which may have implications for TFF2 expression in GC. These findings warrant further research toward the underlying mechanism of MUC1 influenced the TFF2 methylation.

Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 pathway

“…46 Moreover, MUC1 was associated with methylation of TFF2, a member of secreted peptides, which is also expressed in gastric mucosa and triggers cell migration signaling to promote epithelial repair and involve in GC development. 47 Therefore, MUC1 played a key role in the development of many human cancers including HCC.…”

The Risk of Gastrointestinal Cancer on Daily Intake of Low-Dose BaP in C57BL/6 for 60 Days

“…The overexpression of MUC1 suggests that MUC1 can be rendered as an antibody-based therapeutic target 27 and inhibiting MUC1 expression also could suppress cancer cell migration as a novel therapeutic approach to pancreatic cancer treatment. 28 The overexpression of MUC1 was directly associated with the apoptosis pathway 29 and gastric cancer, 30 indicating it could be considered a high-risk factor for the prognosis of gastrointestinal carcinoma. Szlendak et al 31 reported that decreased expression of MUC2 secreted gel-forming mucin is generally observed in colorectal adenocarcinoma, while increased expression of MUC1 was observed in colorectal cancer, indicating low oral doses of BaP could alter MUC expression via colonic injury.…”

A prognosis marker MUC1 correlates with metabolism and drug resistance in bladder cancer: a bioinformatics research

“…The types and abundance of immune cell infiltration in the tumor microenvironment have proved to be very different from normal tissues [ 14 ]. Studies have found that the expression of MUC1 induces immune suppression in colon cancer, and this suppression can be reversed by blocking the PD1/PDL1 pathway [ 15 ]. MUC1 has shown a strong potential in the diagnosis and treatment of tumors.…”